Distinct impacts of sleep-disordered breathing on glycemic variability in patients with and without diabetes mellitus

PLoS One. 2017 Dec 19;12(12):e0188689. doi: 10.1371/journal.pone.0188689. eCollection 2017.

Abstract

Background: Sleep-disordered breathing (SDB) is highly prevalent in patients with diabetes mellitus (DM) and heart failure (HF) and contributes to poor cardiovascular outcomes. Enlarged glycemic variability (GV) is a risk factor of cardiac events independently of average blood glucose level, but the influence of SDB on GV is uncertain. In this study, we examined whether the impact of SDB on GV is modified by the presence of DM with or without HF.

Methods and results: Two hundred three patients (67.5±14.1 [SD] years old, 132 males) who were admitted to our institute for examination or treatment of DM and/or HF underwent continuous glucose monitoring and polysomnography. Both HbA1c (8.0±2.0 vs. 5.7±0.4%) and mean amplitude of glycemic excursion (MAGE, median: 95.5 vs. 63.5 mg/dl) were significantly higher in a DM group (n = 100) than in a non-DM group (n = 103), but apnea-hypopnea index (AHI: 29.0±22.7 vs. 29.3±21.5) was similar in the two groups. AHI was correlated with log MAGE in the non-DM group but not in the DM group, and multivariate regression analysis revealed that AHI was an independent variable for log MAGE in the non-DM group but not in the DM group. We then divided the non-DM patients into two subgroups according to BNP level (100 pg/ml). AHI was positively correlated with log MAGE (r = 0.74, p<0.001) in the non-DM low-BNP subgroup, but such a correlation was not found in the non-DM high-BNP subgroup. Continuous positive airway pressure (CPAP) reduced MAGE from 75.3 to 53.0 mg/dl in the non-DM group but did not reduce MAGE in the DM group.

Conclusion: Severity of SDB was associated with higher GV, but DM as well as HF diminished the contribution of SDB to GV. Treatment with CPAP was effective for reduction of GV only in patients without DM.

MeSH terms

  • Aged
  • Blood Glucose / metabolism*
  • Blood Glucose Self-Monitoring
  • Continuous Positive Airway Pressure
  • Diabetes Mellitus, Type 2 / complications*
  • Diabetes Mellitus, Type 2 / physiopathology
  • Female
  • Humans
  • Male
  • Multivariate Analysis
  • Natriuretic Peptide, Brain / metabolism
  • Regression Analysis
  • Respiration
  • Sleep
  • Sleep Apnea Syndromes / complications*
  • Sleep Apnea Syndromes / physiopathology
  • Sleep Apnea Syndromes / therapy

Substances

  • Blood Glucose
  • Natriuretic Peptide, Brain

Grants and funding

This study was supported by Hokkaido Heart Association Grant for Research, a grant from Philips Respironics and Novartis Pharma Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.